Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Samsung Biologics (207940 KS)
Watchlist
331
Analysis
Health Care
•
South Korea
Samsung Biologics Co.,Ltd. manufactures bio-healthcare products. The Company develops, refines, and distributes biopharmaceutical products.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Hyundai Mobis
•
09 Aug 2018 08:05
Hyundai Motor Group Restructuring Update - Revised Plan Summary
We had another interesting day yesterday. Samsung made a headline with its jaw-dropping investment size (a total ₩180tril). Samsung Biologics Co.,...
Sanghyun Park
Follow
456 Views
Share
bullish
•
Samsung Sds
•
08 Aug 2018 15:51
Samsung Group Plans to Invest 180 Trillion Won in the Next Three Years
The Samsung Group announced a major plan today to invest 180 trillion won (about US$160 billion) in the next three years, including in major...
Douglas Kim
Follow
346 Views
Share
bearish
•
Celltrion Inc
•
08 Aug 2018 03:59
Celltrion: Manufacturing Risks Remain
Celltrion Inc (068270 KS) continues to struggle with meeting the USFDA's standards for Good Manufacturing Practices. The agency issued a Form 483...
Kemp Dolliver, CFA
417 Views
Share
bullish
•
SK Inc
•
14 Jul 2018 10:38
SK Holdings (034730 KS): AMPAC Acquisition - Summary & Ramifications
SK Holdings Co Ltd (034730 KS) said in a regulatory filing that it had acquired a 100% stake in Fine Chemicals Holdings Corp. which is the parent...
Sanghyun Park
Follow
665 Views
Share
bullish
•
Samsung Biologics
•
13 Jul 2018 01:56
Samsung BioLogics (207940 KS): Korea FSC Ruling Summary & Clarifications
This Korea FSC's final ruling on Samsung Biologics Co., Ltd (207940 KS)'s accounting fraud case is very confusing. So, let me walk you...
Sanghyun Park
Follow
827 Views
Share
First
Previous
47
48
49
50
51
52
53
Next
Last
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.40.5
x